130 related articles for article (PubMed ID: 18588518)
21. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A.
Li SC; Gish G; Yang D; Coffey AJ; Forman-Kay JD; Ernberg I; Kay LE; Pawson T
Curr Biol; 1999 Dec; 9(23):1355-62. PubMed ID: 10607564
[TBL] [Abstract][Full Text] [Related]
22. The amino-terminal Src homology 2 domain of phospholipase C gamma 1 is essential for TCR-induced tyrosine phosphorylation of phospholipase C gamma 1.
Stoica B; DeBell KE; Graham L; Rellahan BL; Alava MA; Laborda J; Bonvini E
J Immunol; 1998 Feb; 160(3):1059-66. PubMed ID: 9570517
[TBL] [Abstract][Full Text] [Related]
23. Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F.
Gery S; Cao Q; Gueller S; Xing H; Tefferi A; Koeffler HP
J Leukoc Biol; 2009 Jun; 85(6):957-65. PubMed ID: 19293402
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction.
Lennartsson J; Blume-Jensen P; Hermanson M; Pontén E; Carlberg M; Rönnstrand L
Oncogene; 1999 Sep; 18(40):5546-53. PubMed ID: 10523831
[TBL] [Abstract][Full Text] [Related]
25. Enhanced prediction of Src homology 2 (SH2) domain binding potentials using a fluorescence polarization-derived c-Met, c-Kit, ErbB, and androgen receptor interactome.
Leung KK; Hause RJ; Barkinge JL; Ciaccio MF; Chuu CP; Jones RB
Mol Cell Proteomics; 2014 Jul; 13(7):1705-23. PubMed ID: 24728074
[TBL] [Abstract][Full Text] [Related]
26. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
[TBL] [Abstract][Full Text] [Related]
27. Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584.
Vogel W; Ullrich A
Cell Growth Differ; 1996 Dec; 7(12):1589-97. PubMed ID: 8959326
[TBL] [Abstract][Full Text] [Related]
28. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
[TBL] [Abstract][Full Text] [Related]
29. Enhanced hematopoiesis by hematopoietic progenitor cells lacking intracellular adaptor protein, Lnk.
Takaki S; Morita H; Tezuka Y; Takatsu K
J Exp Med; 2002 Jan; 195(2):151-60. PubMed ID: 11805142
[TBL] [Abstract][Full Text] [Related]
30. Regulation of hematopoietic development in the aorta-gonad-mesonephros region mediated by Lnk adaptor protein.
Nobuhisa I; Takizawa M; Takaki S; Inoue H; Okita K; Ueno M; Takatsu K; Taga T
Mol Cell Biol; 2003 Dec; 23(23):8486-94. PubMed ID: 14612394
[TBL] [Abstract][Full Text] [Related]
31. KIT associated intracellular tyrosines play an essential role in EpoR co-signaling.
Hong L; Ramdas B; Chen J; Harris C; Wojchowski DM; Kapur R
Cell Signal; 2008 Aug; 20(8):1513-20. PubMed ID: 18538998
[TBL] [Abstract][Full Text] [Related]
32. SH2-Balpha is an insulin-receptor adapter protein and substrate that interacts with the activation loop of the insulin-receptor kinase.
Kotani K; Wilden P; Pillay TS
Biochem J; 1998 Oct; 335 ( Pt 1)(Pt 1):103-9. PubMed ID: 9742218
[TBL] [Abstract][Full Text] [Related]
33. Lnk adaptor suppresses radiation resistance and radiation-induced B-cell malignancies by inhibiting IL-11 signaling.
Louria-Hayon I; Frelin C; Ruston J; Gish G; Jin J; Kofler MM; Lambert JP; Adissu HA; Milyavsky M; Herrington R; Minden MD; Dick JE; Gingras AC; Iscove NN; Pawson T
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20599-604. PubMed ID: 24297922
[TBL] [Abstract][Full Text] [Related]
34. Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation.
De Sepulveda P; Okkenhaug K; Rose JL; Hawley RG; Dubreuil P; Rottapel R
EMBO J; 1999 Feb; 18(4):904-15. PubMed ID: 10022833
[TBL] [Abstract][Full Text] [Related]
35. Stat1 associates with c-kit and is activated in response to stem cell factor.
Deberry C; Mou S; Linnekin D
Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):73-80. PubMed ID: 9355737
[TBL] [Abstract][Full Text] [Related]
36. Direct binding of Cbl to Tyr568 and Tyr936 of the stem cell factor receptor/c-Kit is required for ligand-induced ubiquitination, internalization and degradation.
Masson K; Heiss E; Band H; Rönnstrand L
Biochem J; 2006 Oct; 399(1):59-67. PubMed ID: 16780420
[TBL] [Abstract][Full Text] [Related]
37. c-kit ligand stimulates tyrosine phosphorylation of the c-Cbl protein in human hematopoietic cells.
Wisniewski D; Strife A; Clarkson B
Leukemia; 1996 Sep; 10(9):1436-42. PubMed ID: 8751459
[TBL] [Abstract][Full Text] [Related]
38. Flt3 signaling involves tyrosyl-phosphorylation of SHP-2 and SHIP and their association with Grb2 and Shc in Baf3/Flt3 cells.
Zhang S; Mantel C; Broxmeyer HE
J Leukoc Biol; 1999 Mar; 65(3):372-80. PubMed ID: 10080542
[TBL] [Abstract][Full Text] [Related]
39. Functional effects of APS and SH2-B on insulin receptor signalling.
Ahmed Z; Pillay TS
Biochem Soc Trans; 2001 Aug; 29(Pt 4):529-34. PubMed ID: 11498022
[TBL] [Abstract][Full Text] [Related]
40. Adaptor protein Lnk inhibits c-Fms-mediated macrophage function.
Gueller S; Goodridge HS; Niebuhr B; Xing H; Koren-Michowitz M; Serve H; Underhill DM; Brandts CH; Koeffler HP
J Leukoc Biol; 2010 Oct; 88(4):699-706. PubMed ID: 20571037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]